Gangjun Lei

960 total citations · 1 hit paper
23 papers, 653 citations indexed

About

Gangjun Lei is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gangjun Lei has authored 23 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Oncology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gangjun Lei's work include Immunotherapy and Immune Responses (10 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Gangjun Lei is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Gangjun Lei collaborates with scholars based in United States, Canada and Belgium. Gangjun Lei's co-authors include H. Kim Lyerly, Zachary C. Hartman, Michael A. Morse, Takuya Osada, Timothy M. Clay, Jun-Ping Wei, Oliver Glass, Xiaoyi Yang, Xiao Yang and Amy Hobeika and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Cancer Research.

In The Last Decade

Gangjun Lei

22 papers receiving 645 citations

Hit Papers

Effective extracellular payload release and immunomodulat... 2025 2026 2025 5 10 15 20 25

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gangjun Lei United States 14 317 288 273 131 112 23 653
Jinny Kim United Kingdom 6 259 0.8× 181 0.6× 412 1.5× 53 0.4× 139 1.2× 8 640
Victoria A. Brentville United Kingdom 12 267 0.8× 311 1.1× 424 1.6× 54 0.4× 49 0.4× 31 606
Stefanie Loeser Austria 7 301 0.9× 341 1.2× 479 1.8× 89 0.7× 117 1.0× 7 813
Brian J. Czerniecki United States 12 342 1.1× 180 0.6× 413 1.5× 69 0.5× 68 0.6× 23 615
Dahlia M. Besmer United States 11 317 1.0× 397 1.4× 213 0.8× 111 0.8× 80 0.7× 14 679
J Xiang Canada 13 180 0.6× 284 1.0× 186 0.7× 94 0.7× 52 0.5× 31 480
Ingrid Ljuslinder Sweden 17 376 1.2× 402 1.4× 167 0.6× 123 0.9× 66 0.6× 40 800
Ling Tian China 11 189 0.6× 290 1.0× 271 1.0× 61 0.5× 53 0.5× 20 500
Laurie Graham United States 12 211 0.7× 277 1.0× 208 0.8× 53 0.4× 85 0.8× 13 565
Ronald J. Fecek United States 11 176 0.6× 198 0.7× 283 1.0× 63 0.5× 36 0.3× 18 500

Countries citing papers authored by Gangjun Lei

Since Specialization
Citations

This map shows the geographic impact of Gangjun Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gangjun Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gangjun Lei more than expected).

Fields of papers citing papers by Gangjun Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gangjun Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gangjun Lei. The network helps show where Gangjun Lei may publish in the future.

Co-authorship network of co-authors of Gangjun Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Gangjun Lei. A scholar is included among the top collaborators of Gangjun Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gangjun Lei. Gangjun Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsao, Li-Chung, John S. Wang, Simrinder Singh Sodhi, et al.. (2025). Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd). Nature Communications. 16(1). 3167–3167. 29 indexed citations breakdown →
2.
Lei, Gangjun, et al.. (2025). The E3 ubiquitin ligase TRIM31 enhances the progression of esophageal cancer through the ubiquitination of BBOX1. Cellular Signalling. 135. 111975–111975.
3.
Wang, Mu‐En, Jun-Ping Wei, Tao Wang, et al.. (2024). Vaccination Against Androgen Receptor Splice Variants to Immunologically Target Prostate Cancer. Vaccines. 12(11). 1273–1273. 3 indexed citations
4.
Trotter, Timothy N., Jun-Ping Wei, Gangjun Lei, et al.. (2024). Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent “NoGlow” Mice. Cancer Research Communications. 4(4). 1050–1062. 1 indexed citations
5.
Lei, Gangjun, Xiaoyi Yang, Tao Wang, et al.. (2024). Vaccines targeting ESR1 activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer. Human Vaccines & Immunotherapeutics. 20(1). 2309693–2309693. 6 indexed citations
6.
Trotter, Timothy N., Delila Serra, Tao Wang, et al.. (2023). Dormant tumors circumvent tumor-specific adaptive immunity by establishing a Treg-dominated niche via DKK3. JCI Insight. 8(22). 6 indexed citations
7.
Tsao, Li-Chung, Erika J. Crosby, Timothy N. Trotter, et al.. (2022). Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis. JCI Insight. 7(6). 31 indexed citations
8.
Tsao, Li-Chung, Chaitanya R. Acharya, Timothy N. Trotter, et al.. (2022). Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression. Journal for ImmunoTherapy of Cancer. 10(3). e003721–e003721. 12 indexed citations
9.
Trotter, Timothy N., Casey W. Shuptrine, Li-Chung Tsao, et al.. (2020). IL26, a Noncanonical Mediator of DNA Inflammatory Stimulation, Promotes TNBC Engraftment and Progression in Association with Neutrophils. Cancer Research. 80(15). 3088–3100. 23 indexed citations
10.
Xu, Ren-Huan, Tao Wang, Jun-Ping Wei, et al.. (2020). HER2-LAMP vaccines effectively traffic to endolysosomal compartments and generate enhanced polyfunctional T cell responses that induce complete tumor regression. Journal for ImmunoTherapy of Cancer. 8(1). e000258–e000258. 13 indexed citations
11.
Tsao, Li-Chung, Erika J. Crosby, Timothy N. Trotter, et al.. (2019). CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis. JCI Insight. 4(24). 83 indexed citations
13.
Ren, Xiu-Rong, Jun-Ping Wei, Gangjun Lei, et al.. (2012). Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells. Breast Cancer Research. 14(3). R89–R89. 29 indexed citations
14.
Hartman, Zachary C., Xiaoyi Yang, Oliver Glass, et al.. (2011). HER2 Overexpression Elicits a Proinflammatory IL-6 Autocrine Signaling Loop That Is Critical for Tumorigenesis. Cancer Research. 71(13). 4380–4391. 111 indexed citations
15.
Hartman, Zachary C., Jun-Ping Wei, Oliver Glass, et al.. (2011). Increasing vaccine potency through exosome antigen targeting. Vaccine. 29(50). 9361–9367. 157 indexed citations
16.
Hartman, Zachary C., Takuya Osada, Oliver Glass, et al.. (2010). Ligand-Independent Toll-like Receptor Signals Generated by Ectopic Overexpression of MyD88 Generate Local and Systemic Antitumor Immunity. Cancer Research. 70(18). 7209–7220. 32 indexed citations
17.
Hartman, Zachary C., Jun-Ping Wei, Takuya Osada, et al.. (2010). An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity. Clinical Cancer Research. 16(5). 1466–1477. 21 indexed citations
18.
Morse, Michael A., Jun-Ping Wei, Zachary C. Hartman, et al.. (2009). Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo. International Journal of Cancer. 126(12). 2893–2903. 19 indexed citations
19.
Osada, Takuya, Matthew McKinney, Xiao Yang, et al.. (2009). Induction of Wilms' Tumor Protein (WT1)–Specific Antitumor Immunity Using a Truncated WT1-Expressing Adenovirus Vaccine. Clinical Cancer Research. 15(8). 2789–2796. 13 indexed citations
20.
Wei, Jun-Ping, Takuya Osada, Xiao Yang, et al.. (2007). Adenovirus-human HER2 vaccine inhibits breast cancer growth and vaccine induced antibodies (VIA) are efficacious against Herceptin-refractory human breast cancer (48.32). The Journal of Immunology. 178(1_Supplement). S81–S81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026